Weihao Xu's most recent trade in CASI Pharmaceuticals Inc was a trade of 800,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 16, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CASI Pharmaceuticals Inc | Weihao Xu | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 800,000 | 800,000 | - | - | Employee Stock Option (Right to Buy) | |
| CASI Pharmaceuticals Inc | Weihao Xu | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.63 per share. | 16 Dec 2020 | 2,279 | 10,000 (0%) | 0% | 2.6 | 5,994 | Common Stock |
| CASI Pharmaceuticals Inc | Weihao Xu | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.44 per share. | 16 Dec 2020 | 2,000 | 6,000 (0%) | 0% | 2.4 | 4,880 | Common Stock |
| CASI Pharmaceuticals Inc | Weihao Xu | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.64 per share. | 16 Dec 2020 | 1,721 | 7,721 (0%) | 0% | 2.6 | 4,543 | Common Stock |